MISSISSAUGA, Ontario, September 16, 2025--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced ...
Velano Vascular said it has achieved U.S. Food and Drug Administration (FDA) 510(k) clearance for PIVO™, its needle-free vascular access device. The device is meant to allow for ease-of-use and high ...
Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs) Peer-reviewed study ...
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the publication of results from a peer-reviewed clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results